HomeCompareCGROF vs JNJ

CGROF vs JNJ: Dividend Comparison 2026

CGROF yields 2.47% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CGROF wins by $5.6K in total portfolio value
10 years
CGROF
CGROF
● Live price
2.47%
Share price
$3.26
Annual div
$0.08
5Y div CAGR
8.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$707.85
Full CGROF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CGROF vs JNJ

📍 CGROF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGROFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGROF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CGROF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGROF
Annual income on $10K today (after 15% tax)
$210.23/yr
After 10yr DRIP, annual income (after tax)
$601.67/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $101.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGROF + JNJ for your $10,000?

CGROF: 50%JNJ: 50%
100% JNJ50/50100% CGROF
Portfolio after 10yr
$22.8K
Annual income
$767.81/yr
Blended yield
3.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CGROF
No analyst data
Altman Z
5.0
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGROF buys
0
JNJ buys
0
No recent congressional trades found for CGROF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGROFJNJ
Forward yield2.47%3.36%
Annual dividend / share$0.08$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR8.5%5.8%
Portfolio after 10y$25.6K$20.0K
Annual income after 10y$707.85$827.78
Total dividends collected$4.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CGROF vs JNJ ($10,000, DRIP)

YearCGROF PortfolioCGROF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,968$268.36$10,676$355.77+$292.00CGROF
2$12,035$298.47$11,407$389.39+$628.00CGROF
3$13,209$332.08$12,198$426.53+$1.0KCGROF
4$14,503$369.59$13,056$467.62+$1.4KCGROF
5$15,930$411.50$13,987$513.12+$1.9KCGROF
6$17,503$458.31$14,998$563.56+$2.5KCGROF
7$19,239$510.64$16,098$619.52+$3.1KCGROF
8$21,155$569.15$17,295$681.69+$3.9KCGROF
9$23,271$634.60$18,599$750.82+$4.7KCGROF
10$25,608$707.85$20,022$827.78+$5.6KCGROF

CGROF vs JNJ: Complete Analysis 2026

CGROFStock

The Character Group plc designs, develops, and distributes toys, games, and gifts in the United Kingdom and internationally. The company sells its products under the Goo Jit Zu, Peppa Pig, Pokémon, Little Live Pets, Shimmer 'n Sparkle, Treasure X, Instaglam, Mashems, Teletubbies, and Ben & Holly's Little Kingdom brands. It also imports and distributes gifts; and invests in properties. The Character Group plc was founded in 1991 and is headquartered in New Malden, the United Kingdom.

Full CGROF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CGROF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGROF vs SCHDCGROF vs JEPICGROF vs OCGROF vs KOCGROF vs MAINCGROF vs ABBVCGROF vs MRKCGROF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.